Analysts hold mixed views as Healthcare formally launches partial offer for Abano
Fisher Funds has a diametrically opposed view of the company from Healthcare Partners.
Jenny Ruth
Mon, 12 Dec 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Abano Healthcare’s second-largest shareholder, Fisher Funds, says the company is “a rare New Zealand business” with both a strong track record of creating value for shareholders and with a long growth runway ahead.
Fisher Funds’ assessment comes as Healthcare Partners, Abano’s largest
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Jenny Ruth
Mon, 12 Dec 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.